Clinical Trial Update: A First-in-Human Study Evaluating AGA2115 in Adult Healthy Volunteers [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 trial evaluating AGA2115 in adult healthy volunteers has completed, investigating safety and pharmacology in relation to Osteogenesis I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteogenesis Imperfecta

Drugs mentioned

• AGA2115

Snippet

Sponsor: Angitia Incorporated Limited | Conditions: Osteogenesis Imperfecta | Phase 1 | Status: COMPLETED